Natesto nasal gel
NDC 42667-5511, testosterone, gel, metered, from Acerus Pharmaceuticals Corporation.
- Product NDC
- 42667-5511
- Status
- Listed
- Labeler
- Acerus Pharmaceuticals Corporation
- Dosage form
- GEL, METERED
- Route
- NASAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205488
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/42667-5511 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TESTOSTERONE5.5 mg/.122g
Pharmacologic classes
Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42667-5511-1 | 42667551101 | 1 APPLICATOR in 1 BOX (42667-5511-1) / 11 g in 1 APPLICATOR |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/dea6bed1-eaca-11e3-ac10-0800200c9a66NADAC price for package 42667551101
GET /v1/drugs/nadac/42667551101
Use it
Look up 42667-5511 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42667-5511 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42667-5511. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.